NCT02534467View on ClinicalTrials.gov

Does Treatment With Montelukast Improve Symptoms of Atopic Dermatitis in Children?

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 9, 2015

Primary Completion Date

December 4, 2018

Study Completion Date

December 4, 2018

Conditions
Dermatitis, Atopic
Interventions
DRUG

Montelukast

daily dose according to age for 8 weeks out of 16 weeks of assessment

Trial Locations (1)

3052

The Royal Children's Hospital, Parkville

Sponsors
All Listed Sponsors
collaborator

Monash University

OTHER

lead

Murdoch Childrens Research Institute

OTHER

NCT02534467 - Does Treatment With Montelukast Improve Symptoms of Atopic Dermatitis in Children? | Biotech Hunter | Biotech Hunter